No to Acta, yes to the right to health

The United Nations Special Rapporteur on the right to health, Anand Grover, praised the European Parliament’s rejection of the Anti-Counterfeiting Trade Agreement (ACTA) on July 4 as a step in the right direction to ensure continued access to affordable and essential drugs and medication essential for the fulfillment of the right to health

Photo: No to Acta, yes to the right to health
Photo: No to Acta, yes to the right to health

According to Grover, ACTA’s defeat in Europe was a welcome blow to the flawed agreement which had failed to address numerous concerns related to access to medicines. In July 2011, the UN Human Rights Council requested the Special Rapporteur to study existing challenges with regard to access to medicines, ways to overcome them and good practices. He will present the study to the Council in June 2013


More on the subject:
Read all latest stories

Related articles


Personalized medicine

FDA approves first targeted therapy for metastatic bladder cancer

The U.S. Food and Drug Administration (FDA) granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type…


Breast healthcare

FDA advances landmark policy changes to modernize mammography services

The U.S. Food and Drug Administration (FDA) announced important new steps to modernize breast cancer screening and help empower patients with more information when they are considering important…


Open letter

COCIR concerns in the event of a no-deal Brexit

COCIR, the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry, published an open letter to the European Commission & National Competent Authorities for…